{"id":"https://openalex.org/W2078839736","doi":"https://doi.org/10.1016/s0378-5173(97)00293-7","title":"Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water-soluble polymer","display_name":"Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water-soluble polymer","publication_year":1998,"publication_date":"1998-01-01","ids":{"openalex":"https://openalex.org/W2078839736","doi":"https://doi.org/10.1016/s0378-5173(97)00293-7","mag":"2078839736"},"language":"en","primary_location":{"id":"doi:10.1016/s0378-5173(97)00293-7","doi":"https://doi.org/10.1016/s0378-5173(97)00293-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0378-5173(97)00293-7","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051532153","display_name":"Masaaki Sugimoto","orcid":"https://orcid.org/0000-0003-4781-3589","observed_orcids":["https://orcid.org/0000-0003-4781-3589"]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Masaaki Sugimoto","raw_affiliation_strings":["Pharmaceutics Research Laboratory, Tanabe Seiyaku, 16-89 Kashima 3-chome, Yodogawa-ku, Osaka 532, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics Research Laboratory, Tanabe Seiyaku, 16-89 Kashima 3-chome, Yodogawa-ku, Osaka 532, Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084864633","display_name":"Takuya Okagaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takuya Okagaki","raw_affiliation_strings":["Pharmaceutics Research Laboratory, Tanabe Seiyaku, 16-89 Kashima 3-chome, Yodogawa-ku, Osaka 532, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics Research Laboratory, Tanabe Seiyaku, 16-89 Kashima 3-chome, Yodogawa-ku, Osaka 532, Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066123098","display_name":"Shinji Narisawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinji Narisawa","raw_affiliation_strings":["Pharmaceutics Research Laboratory, Tanabe Seiyaku, 16-89 Kashima 3-chome, Yodogawa-ku, Osaka 532, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics Research Laboratory, Tanabe Seiyaku, 16-89 Kashima 3-chome, Yodogawa-ku, Osaka 532, Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037626956","display_name":"YOSHIYUKI KOIDA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiyuki Koida","raw_affiliation_strings":["Pharmaceutics Research Laboratory, Tanabe Seiyaku, 16-89 Kashima 3-chome, Yodogawa-ku, Osaka 532, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics Research Laboratory, Tanabe Seiyaku, 16-89 Kashima 3-chome, Yodogawa-ku, Osaka 532, Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060842250","display_name":"Kingo NAKAJIMA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kingo Nakajima","raw_affiliation_strings":["Pharmaceutics Research Laboratory, Tanabe Seiyaku, 16-89 Kashima 3-chome, Yodogawa-ku, Osaka 532, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics Research Laboratory, Tanabe Seiyaku, 16-89 Kashima 3-chome, Yodogawa-ku, Osaka 532, Japan","institution_ids":["https://openalex.org/I4387155982"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5051532153"],"corresponding_institution_ids":["https://openalex.org/I4387155982"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":4.1248,"has_fulltext":false,"cited_by_count":186,"citation_normalized_percentile":{"value":0.94988506,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"160","issue":"1","first_page":"11","last_page":"19"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/co-grinding","display_name":"co-grinding","score":0.9509999752044678},{"id":"https://openalex.org/keywords/poorly-water-soluble-drugs","display_name":"poorly water-soluble drugs","score":0.9810000061988831},{"id":"https://openalex.org/keywords/nifedipine","display_name":"nifedipine","score":0.8199999928474426},{"id":"https://openalex.org/keywords/peg-6000","display_name":"polyethylene glycol 6000","score":0.9390000104904175},{"id":"https://openalex.org/keywords/hydroxypropyl-methylcellulose","display_name":"hydroxypropyl methylcellulose","score":0.9520000219345093},{"id":"https://openalex.org/keywords/dissolution-enhancement","display_name":"dissolution enhancement","score":0.6819999814033508},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.906000018119812},{"id":"https://openalex.org/keywords/drug-polymer-interactions","display_name":"drug-polymer interactions","score":0.8939999938011169},{"id":"https://openalex.org/keywords/indomethacin","display_name":"indomethacin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.4090000092983246},{"id":"https://openalex.org/keywords/amorphous-phase","display_name":"amorphous phase","score":0.6029999852180481}],"concepts":[{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.8591943979263306},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.8410752415657043},{"id":"https://openalex.org/C83029808","wikidata":"https://www.wikidata.org/wiki/Q1154463","display_name":"Coacervate","level":2,"score":0.8213579058647156},{"id":"https://openalex.org/C2776964284","wikidata":"https://www.wikidata.org/wiki/Q410083","display_name":"Polyethylene glycol","level":2,"score":0.7442353963851929},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.7302982807159424},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7089093327522278},{"id":"https://openalex.org/C54400483","wikidata":"https://www.wikidata.org/wiki/Q1793202","display_name":"PEG ratio","level":2,"score":0.5300744771957397},{"id":"https://openalex.org/C56052488","wikidata":"https://www.wikidata.org/wiki/Q103382","display_name":"Amorphous solid","level":2,"score":0.49545109272003174},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.4854041039943695},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4409995675086975},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.42009836435317993},{"id":"https://openalex.org/C2781218482","wikidata":"https://www.wikidata.org/wiki/Q724426","display_name":"Hydroxypropyl cellulose","level":3,"score":0.4158819615840912},{"id":"https://openalex.org/C13965031","wikidata":"https://www.wikidata.org/wiki/Q243545","display_name":"Nuclear chemistry","level":1,"score":0.3508278727531433},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.2004069685935974},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.14934831857681274},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0378-5173(97)00293-7","doi":"https://doi.org/10.1016/s0378-5173(97)00293-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0378-5173(97)00293-7","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W78092535","https://openalex.org/W1556719932","https://openalex.org/W1986829836","https://openalex.org/W2035384210","https://openalex.org/W2145126588","https://openalex.org/W2319555277","https://openalex.org/W2323367009","https://openalex.org/W2417723533","https://openalex.org/W2417796683","https://openalex.org/W2418673867"],"related_works":["https://openalex.org/W2111151724","https://openalex.org/W2065769066","https://openalex.org/W1796086075","https://openalex.org/W2081007162","https://openalex.org/W1974906071","https://openalex.org/W2025905362","https://openalex.org/W2091492446","https://openalex.org/W2034484297","https://openalex.org/W2053900295","https://openalex.org/W2622010212"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":17}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}